Gabelli Securities »

Cerevel Therapeutics Hldng I shares owned by Gabelli Securities

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Gabelli Securities from 13F filings

Historical chart of Gabelli Securities investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Gabelli Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Gabelli Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $6.7M 164k 40.89
2024-03-31 $19M 448k 42.27
2023-12-31 $12M 276k 42.40

More positions owned by Gabelli Securities

Hess Corp Equity (HES)
Hashicorp Inc-cl A Equity (HCP)
Endeavor Group Hold-class A Equity (EDR)
Amedisys Equity (AMED)
Albertsons Cos Inc - Class A Equity (ACI)
United States Steel Corp Equity (X)
Everbridge Equity (EVBG)
Catalent Equity (CTLT)
Juniper Networks Equity (JNPR)
Axonics Equity (AXNX)
Gdl Fund Exchange Traded (GDL)
Gabelli Dividend & Income Tr Exchange Traded (GDV)
Pnm Resources Equity (PNM)
Capri Holdings Equity (CPRI)
Equitrans Midstream Corp Equity (ETRN)

View all positions for Gabelli Securities

Top funds holding Cerevel Therapeutics Hldng I

Bain Capital Investors
Perceptive Advisors
venBio Select Advisor
Vanguard Group
BlackRock
Fil
State Street Corporation
Millennium Management
Alpine Associates Management
Paradigm Biocapital Advisors
Pentwater Capital Management
Soros Fund Management
LMR Partners
Marshall Wace
FMR

View all funds holding Cerevel Therapeutics Hldng I